logo

For the Inventor, By the Inventor

Maryland Heights, MO, United States of America

Kevin C Glenn

This inventor holds 18 USPTO granted patents, primarily in Cardiovascular Therapies. Top assignees: G.d. Searle & Company, G.d. Searle LLC, Pharmacia Corporation. Active years: 1994-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin C Glenn. Retrieved from https://idiyas.com/inventor/kevin-c-glenn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 77.8

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 253(Granted Patents)


Location History:

  • St. Louis, MO (US) (1994 - 2003)
  • Maryland Heights, MO (US) (1996 - 2005)

Company Filing History:

goldMedal6 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal6 out of 33 
 
G.d. Searle LLC
 patents
bronzeMedal2 out of 220 
 
Pharmacia Corporation
 patents
4. 1 out of 3,289 
 
Monsanto Company
 patents
5. 1 out of 5,640 
 
The University of Texas System
 patents
6. 3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2005

Loading Chart...
Areas of Expertise:
Bile Acid Transport Inhibitors
Cholesteryl Ester Transfer Protein
Combination Therapy
Cardiovascular Indications
HMG Co-A Reductase
Nicotinic Acid Derivatives
Fibric Acid Derivatives
Thrombin Derived Polypeptides
Substituted Pyridines
Compositions and Methods
18 patents (USPTO):Explore Patents
1. 6943189 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors (2005-09-13),
2. 6890958 - Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications (2005-05-10),
3. 6794396 - Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity (2004-09-21),
4. 6642268 - Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors (2003-11-04),
5. 6638969 - Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications (2003-10-28),
6. 6630572 - Thrombin derived polypeptides: compositions and methods for use (2003-10-07),
7. 6627731 - Thrombin derived polypeptides; compositions and methods for use (2003-09-30),
8. 6605624 - Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity (2003-08-12),
9. 6569905 - Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications (2003-05-27),
10. 6562860 - Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications (2003-05-13),
11. 6489366 - Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications (2002-12-03),
12. 6462091 - Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications (2002-10-08),
13. 6458851 - Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications (2002-10-01),
14. 6458850 - Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications (2002-10-01),
15. 6420417 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors (2002-07-16),

Title: Inventor Kevin C Glenn - Revolutionizing Technology

Introduction: Kevin C Glenn, a visionary inventor based in Maryland Heights, MO, is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Kevin C Glenn holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Kevin C Glenn has worked with leading tech companies to develop cutting-edge solutions that have revolutionized industries worldwide. His keen eye for innovation and problem-solving skills have earned him a reputation as a trailblazer in the field.

Collaborations: Throughout his career, Kevin C Glenn has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of numerous groundbreaking projects.

Conclusion: In conclusion, Kevin C Glenn's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a prominent figure in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…